article thumbnail

CEOs Should Get Out of the Saddle Before They’re Pushed Out

Harvard Business Review

I can’t help but think of the Mel Brooks film Blazing Saddles — a satirical comedy of what happens when a new sheriff comes to town. Recent events have seen a rash of the departures from large corporates: Steve Ballmer from MicroSoft, Jeremy Levin from Teva Pharmaceutical, and Thorsten Heins from Blackberry.

CEO 13
article thumbnail

Four Suggestions as You Face Your Industry's Steamroller

Harvard Business Review

Remember the scene in the first Austin Powers film where Powers, attempting to escape in a steamroller, warns one of Dr. Evil''s henchman to move out of its path? Consider the pharmaceutical industry, the focus of a recent global survey my colleagues and I conducted. until it''s too late. Only, it''s not at all funny.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Quiet Revolution in Clean-Energy Finance

Harvard Business Review

When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive. Since energy startups operate in an ecosystem dominated by incumbents, they can benefit dramatically from use of incumbent resources.

Energy 10
article thumbnail

Deep questions: What diving teaches us about uncertainty and risk

Chartered Management Institute

Since founding the Human Diver in 2016, Gareth has given risk training to a wide variety of organisations, from oil and gas and construction to pharmaceuticals and software. So we need to look at the context and not just focus on the immediate reasons why the adverse event occurred.”

article thumbnail

How Corporate Venture Capital Helps Firms Explore New Territory

Harvard Business Review

In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise. You can see why: For decades in the U.S., But cutting back on research funding doesn''t work either.

article thumbnail

How Corporate Venture Capital Helps Firms Explore New Territory

Harvard Business Review

In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise. You can see why: For decades in the U.S., But cutting back on research funding doesn’t work either.

article thumbnail

What Is a Robot, Anyway?

Harvard Business Review

For Westerners at least, our working cultural definition owes a lot to robots in stories and film, as well as real-life robots past and present. million industrial robots are in use or available in various industries including automotive, electronics, rubber and plastics, cosmetics, pharmaceutical, and food and beverage.